Predilife S.A. (EPA:ALPRE)

Market Cap	10.50M -24.1%
Revenue (ttm)	728.08K +142.0%
Net Income	-3.80M
EPS	-1.00
Shares Out	3.78M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Average Volume	739
Open	2.770
Previous Close	2.780
Day's Range	2.770 - 2.770
52-Week Range	2.570 - 4.250
Beta	0.26
RSI	35.69
Earnings Date	Jul 15, 2026

About Predilife

Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer prediction test based on the patient’s individual risk; and DenSeeMammo, a breast density measurement software. Predilife S.A. was incorporated in 2004 and...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2004
• Employees: 27
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALPRE

Financial Performance

In 2024, Predilife's revenue was 493,202, an increase of 55.20% compared to the previous year's 317,794. Losses were -4.26 million, 0.96% more than in 2023.